CANCER GENETICS INC - COM (CGIX)

CUSIP: 13739U104

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / COM
Total 13F shares
4,105,497
Share change
-661,500
Total reported value
$3,655,000
Price per share
$0.89
Number of holders
19
Value change
-$671,068
Number of buys
9
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 13739U104?
CUSIP 13739U104 identifies CGIX - CANCER GENETICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CANCER GENETICS INC - COM (CGIX) as of Q2 2018

As of 30 Jun 2018, CANCER GENETICS INC - COM (CGIX) was held by 19 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,105,497 shares. The largest 10 holders included Stonepine Capital Management, LLC, PERKINS CAPITAL MANAGEMENT INC, RENAISSANCE TECHNOLOGIES LLC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, VANGUARD GROUP INC, Fairbanks Capital Management, Inc., GEODE CAPITAL MANAGEMENT, LLC, DIKER MANAGEMENT LLC, WEDBUSH SECURITIES INC, and PANAGORA ASSET MANAGEMENT INC. This page lists 19 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.